Advertisement
Screener

Decoy Therapeutics Inc. (DCOY) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period

2.2 / 5 stars · 36/82 Roast Me

Decoy Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period

Decoy Therapeutics Inc. (DCOY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-12

  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 1.38K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month
2026-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
0.00 shares
10-Q · filed 2026-08-12
0.00 shares
derived: sum of 3 quarters · filed 2026-08-12
0.00 shares
derived: sum of 4 quarters · filed 2026-08-12
2026-03-310.00 shares
10-Q · filed 2026-05-08
0.00 shares
derived: sum of 2 quarters · filed 2026-05-08
0.00 shares
derived: sum of 3 quarters · filed 2026-05-08
0.00 shares
derived: sum of 4 quarters · filed 2026-08-12
2025-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
0.00 shares
derived: sum of 2 quarters · filed 2026-03-31
0.00 shares
derived: sum of 3 quarters · filed 2026-08-12
0.00 shares
10-K · filed 2026-03-31
2025-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
0.00 shares
derived: sum of 2 quarters · filed 2026-08-12
0.00 shares
10-Q · filed 2025-11-14
0.00 shares
derived: sum of 4 quarters · filed 2026-08-12
2025-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
0.00 shares
10-Q · filed 2026-08-12
0.00 shares
derived: sum of 3 quarters · filed 2026-08-12
0.00 shares
derived: sum of 4 quarters · filed 2026-08-12
2025-03-310.00 shares
10-Q · filed 2026-05-08
0.00 shares
derived: sum of 2 quarters · filed 2026-05-08
0.00 shares
derived: sum of 3 quarters · filed 2026-05-08
0.00 shares
derived: sum of 4 quarters · filed 2026-05-08
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
0.00 shares
derived: sum of 2 quarters · filed 2026-03-31
0.00 shares
derived: sum of 3 quarters · filed 2026-03-31
0.00 shares
10-K · filed 2026-03-31
2024-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
0.00 shares
derived: sum of 2 quarters · filed 2025-11-14
0.00 shares
10-Q · filed 2025-11-14
0.00 shares
derived: sum of 4 quarters · filed 2025-11-14
2024-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
0.00 shares
10-Q · filed 2025-08-12
0.00 shares
derived: sum of 3 quarters · filed 2025-08-12
0.00 shares
derived: sum of 4 quarters · filed 2025-08-12
2024-03-310.00 shares
10-Q · filed 2025-05-14
0.00 shares
derived: sum of 2 quarters · filed 2025-05-14
0.00 shares
derived: sum of 3 quarters · filed 2025-05-14
0.00 shares
derived: sum of 4 quarters · filed 2025-05-14
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
0.00 shares
derived: sum of 2 quarters · filed 2025-03-21
0.00 shares
derived: sum of 3 quarters · filed 2025-03-21
0.00 shares
10-K · filed 2025-03-21
2023-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
0.00 shares
derived: sum of 2 quarters · filed 2024-11-14
0.00 shares
10-Q · filed 2024-11-14
0.00 shares
derived: sum of 4 quarters · filed 2024-11-14
2023-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
0.00 shares
10-Q · filed 2024-08-09
0.00 shares
derived: sum of 3 quarters · filed 2024-08-09
1.38K shares
derived: sum of 4 quarters · filed 2024-08-09
2023-03-310.00 shares
10-Q · filed 2024-05-13
0.00 shares
derived: sum of 2 quarters · filed 2024-05-13
1.38K shares
derived: sum of 3 quarters · filed 2024-05-13
1.38K shares
derived: sum of 4 quarters · filed 2024-05-13
2022-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
1.38K shares
derived: sum of 2 quarters · filed 2024-03-22
1.38K shares
derived: sum of 3 quarters · filed 2024-03-22
1.38K shares
10-K · filed 2024-03-22
2022-09-301.38K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
1.38K shares
derived: sum of 2 quarters · filed 2023-08-10
1.38K shares
10-Q · filed 2022-11-10
1.38K shares
derived: sum of 4 quarters · filed 2023-08-10
2022-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
0.00 shares
10-Q · filed 2023-08-10
0.00 shares
derived: sum of 3 quarters · filed 2023-08-10
0.00 shares
derived: sum of 4 quarters · filed 2023-08-10
2022-03-310.00 shares
10-Q · filed 2023-05-11
0.00 shares
derived: sum of 2 quarters · filed 2023-05-11
0.00 shares
derived: sum of 3 quarters · filed 2023-05-11
0.00 shares
derived: sum of 4 quarters · filed 2023-05-11
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
0.00 shares
derived: sum of 2 quarters · filed 2023-03-27
0.00 shares
derived: sum of 3 quarters · filed 2023-03-27
0.00 shares
10-K · filed 2023-03-27
2021-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
0.00 shares
derived: sum of 2 quarters · filed 2022-11-10
0.00 shares
10-Q · filed 2022-11-10
3.00K shares
derived: sum of 4 quarters · filed 2022-11-10
2021-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
0.00 shares
10-Q · filed 2022-08-05
3.00K shares
derived: sum of 3 quarters · filed 2022-08-05
33.77K shares
derived: sum of 4 quarters · filed 2022-08-05
2021-03-310.00 shares
10-Q · filed 2022-05-12
3.00K shares
derived: sum of 2 quarters · filed 2022-05-12
33.77K shares
derived: sum of 3 quarters · filed 2022-05-12
33.77K shares
derived: sum of 4 quarters · filed 2022-05-12
2020-12-313.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25
33.77K shares
derived: sum of 2 quarters · filed 2022-03-25
33.77K shares
derived: sum of 3 quarters · filed 2022-03-25
33.77K shares
10-K · filed 2022-03-25
2020-09-3030.77K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
30.77K shares
derived: sum of 2 quarters · filed 2021-11-04
30.77K shares
10-Q · filed 2021-11-04
30.77K shares
derived: sum of 4 quarters · filed 2021-11-04
2020-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
0.00 shares
10-Q · filed 2021-08-05
0.00 shares
derived: sum of 3 quarters · filed 2021-08-05
-23.95K shares
derived: sum of 4 quarters · filed 2021-08-05
2020-03-310.00 shares
10-Q · filed 2021-05-12
0.00 shares
derived: sum of 2 quarters · filed 2021-05-12
-23.95K shares
derived: sum of 3 quarters · filed 2021-05-12
-23.95K shares
derived: sum of 4 quarters · filed 2021-05-12
2019-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
-23.95K shares
derived: sum of 2 quarters · filed 2021-03-18
-23.95K shares
derived: sum of 3 quarters · filed 2021-03-18
0.00 shares
10-K · filed 2021-03-18
2019-09-30-23.95K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-23.95K shares
derived: sum of 2 quarters · filed 2019-11-12
0.00 shares
10-Q · filed 2019-11-12
114.81K shares
derived: sum of 4 quarters · filed 2019-11-12
2019-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-17
23.95K shares
10-Q · filed 2019-07-17
138.76K shares
derived: sum of 3 quarters · filed 2019-07-17
613.52K shares
derived: sum of 4 quarters · filed 2019-07-17
2019-03-3123.95K shares
10-Q · filed 2019-05-01
138.76K shares
derived: sum of 2 quarters · filed 2019-05-01
613.52K shares
derived: sum of 3 quarters · filed 2019-05-01
808.17K shares
derived: sum of 4 quarters · filed 2019-05-01
2018-12-31114.81K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
589.57K shares
derived: sum of 2 quarters · filed 2019-03-06
784.22K shares
derived: sum of 3 quarters · filed 2019-03-06
820.20K shares
10-K · filed 2019-03-06
2018-09-30474.76K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
669.41K shares
derived: sum of 2 quarters · filed 2018-11-05
705.39K shares
10-Q · filed 2018-11-05
2018-06-30194.65K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
230.63K shares
10-Q · filed 2018-08-01
2018-03-3135.98K shares
10-Q · filed 2018-05-02
2017-12-31215.04K shares
10-K · filed 2018-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Silo Pharma, Inc. (SILO)United States$0.003B-1.57